Differential calcium sensitivity in NaV1.5 mixed syndrome mutants

摘要

Key points class="unordered" style="list-style-type:disc" id="tjp12529-list-0001">SCN5a mutations may express gain‐of‐function (Long QT Syndrome‐3), loss‐of‐function (Brugada Syndrome 1) or both (mixed syndromes), depending on the mutation and environmental triggers. One such trigger may be an increase in cytosolic calcium, accompanying exercise.Many mixed syndromes mutants, including ∆KPQ, E1784K, 1795insD and Q1909R, are found in calcium‐sensitive regions.Elevated cytosolic calcium attenuates gain‐of‐function properties in ∆KPQ, 1795insD and Q1909R, but not in E1784K. By contrast, elevated cytosolic calcium further exacerbates gain‐of‐function in E1784K by destabilizing slow inactivation.Action potential modelling, using a modified O'Hara Rudy model, suggests that elevated heart rate rescues action potential duration in ∆KPQ, 1795insD and Q1909R, but not in E1784K.Action potential simulations suggest that E1784K carriers have an increased intracellular sodium‐to‐calcium ratio under bradycardia and tachycardia conditions.Elevated cytosolic calcium, which is common during high heart rates, ameliorates or exacerbates the mixed syndrome phenotype depending on the genetic signature.